Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Clinical and Prognostic Differences among Patients with Light Chain Deposition Disease, Myeloma Cast Nephropathy and Both.

Zand L, Nasr SH, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Kumar S, Kyle RA, Fervenza FC, Sethi S, Dingli D, Rajkumar SV, Kapoor P, McCurdy A, Leung N.

Leuk Lymphoma. 2015 Apr 10:1-27. [Epub ahead of print]

PMID:
25860232
2.

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma.

Gonsalves WI, Leung N, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Kapoor P, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust S, Kyle RA, Gertz MA, Kumar SK.

Blood Cancer J. 2015 Mar 20;5:e296. doi: 10.1038/bcj.2015.20.

3.

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A.

Am J Hematol. 2015 Mar 8. doi: 10.1002/ajh.24001. [Epub ahead of print]

PMID:
25753178
4.

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.

Kaufman GP, Dispenzieri A, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Kapoor P, Go RS, Zeldenrust SR, Kyle RA, Rajkumar SV, Kumar SK.

Am J Hematol. 2015 Mar;90(3):181-6. doi: 10.1002/ajh.23898. Epub 2015 Jan 16.

PMID:
25388651
5.

Scleromyxedema.

Bogner RR, Wetter DA, Dingli D.

Intern Med. 2014;53(21):2561-2. Epub 2014 Nov 1. No abstract available.

6.

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.

Kourelis TV, Kumar SK, Go RS, Kapoor P, Kyle RA, Buadi FK, Gertz MA, Lacy MQ, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Zeldenrust SR, Rajkumar SV, Dispenzieri A.

Am J Hematol. 2014 Nov;89(11):1051-4. doi: 10.1002/ajh.23827. Epub 2014 Sep 2.

PMID:
25111004
7.

The ecology of cancer from an evolutionary game theory perspective.

Pacheco JM, Santos FC, Dingli D.

Interface Focus. 2014 Aug 6;4(4):20140019. doi: 10.1098/rsfs.2014.0019.

PMID:
25097748
8.

Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.

Werner B, Gallagher RE, Paietta EM, Litzow MR, Tallman MS, Wiernik PH, Slack JL, Willman CL, Sun Z, Traulsen A, Dingli D.

Cancer Res. 2014 Oct 1;74(19):5386-96. doi: 10.1158/0008-5472.CAN-14-1210. Epub 2014 Jul 31.

PMID:
25082816
9.

How we manage autologous stem cell transplantation for patients with multiple myeloma.

Gertz MA, Dingli D.

Blood. 2014 Aug 7;124(6):882-90. doi: 10.1182/blood-2014-03-544759. Epub 2014 Jun 27.

10.

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.

Gonsalves WI, Rajkumar SV, Go RS, Dispenzieri A, Gupta V, Singh PP, Buadi FK, Lacy MQ, Kapoor P, Dingli D, Lust JA, Zeldenrust SR, Hayman SR, Kyle RA, Gertz MA, Kumar SK.

Blood. 2014 Aug 7;124(6):907-12. doi: 10.1182/blood-2014-03-565051. Epub 2014 Jun 23.

PMID:
24957143
11.

Remission of disseminated cancer after systemic oncolytic virotherapy.

Russell SJ, Federspiel MJ, Peng KW, Tong C, Dingli D, Morice WG, Lowe V, O'Connor MK, Kyle RA, Leung N, Buadi FK, Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A.

Mayo Clin Proc. 2014 Jul;89(7):926-33. doi: 10.1016/j.mayocp.2014.04.003. Epub 2014 May 14.

12.

Imaging findings in 22 cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the "hot knees" sign differential diagnosis.

Niederhauser BD, Dingli D, Kyle RA, Ringler MD.

Skeletal Radiol. 2014 Jul;43(7):905-15. doi: 10.1007/s00256-014-1857-y. Epub 2014 Mar 21.

PMID:
24652142
13.

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.

Warsame R, Bang SM, Kumar SK, Gertz MA, Lacy MQ, Buadi F, Dingli D, Hayman SR, Kapoor P, Kyle RA, Leung N, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Rajkumar SV, Dispenzieri A.

Eur J Haematol. 2014 Jun;92(6):485-90. doi: 10.1111/ejh.12282. Epub 2014 Mar 2.

PMID:
24502602
14.

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.

Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK, Grogan M, Zeldenrust SR, Hayman SR, Buadi F, Greipp PR, Leung N, Russell SR, Dingli D, Lust JA, Rajkumar SV, Jaffe AS.

Heart. 2014 Mar;100(5):383-8. doi: 10.1136/heartjnl-2013-304957. Epub 2014 Jan 8.

PMID:
24402772
15.

Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients.

McCarthy JT, Hocum CL, Albright RC, Rogers J, Gallaher EJ, Steensma DP, Gudgell SF, Bergstralh EJ, Dillon JC, Hickson LJ, Williams AW, Dingli D.

Mayo Clin Proc. 2014 Jan;89(1):87-94. doi: 10.1016/j.mayocp.2013.10.022.

PMID:
24388026
16.

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy.

Kourelis TV, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust SR, Leung N, Kyle RA, Russell SJ, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Rajkumar SV, Dispenzieri A.

Am J Hematol. 2014 Mar;89(3):302-5. doi: 10.1002/ajh.23634. Epub 2014 Feb 18.

PMID:
24265187
17.

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma.

Kapoor P, Kumar SK, Dispenzieri A, Lacy MQ, Buadi F, Dingli D, Russell SJ, Hayman SR, Witzig TE, Lust JA, Leung N, Lin Y, Zeldenrust SR, McCurdy A, Greipp PR, Kyle RA, Rajkumar SV, Gertz MA.

J Clin Oncol. 2013 Dec 20;31(36):4529-35. doi: 10.1200/JCO.2013.49.0086. Epub 2013 Nov 18.

18.

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.

Kumar SK, Mikhael J, Laplant B, Lacy MQ, Buadi FK, Dingli D, Gertz MA, Laumann K, Miceli T, Mahlman M, Bergsagel LP, Hayman SR, Reeder C, Stewart AK, Dispenzieri A, Gastineau DA, Winters JL.

Bone Marrow Transplant. 2014 Feb;49(2):201-5. doi: 10.1038/bmt.2013.175. Epub 2013 Nov 4.

19.

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV.

Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25.

20.

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.

Kourelis TV, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust S, Leung N, Kyle RA, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Rajkumar SV, McCurdy A, Dispenzieri A.

J Clin Oncol. 2013 Dec 1;31(34):4319-24. doi: 10.1200/JCO.2013.50.8499. Epub 2013 Oct 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk